A little change in payment means a big chance for a lot of ills
Authors:
Lucie Ondřichová
Authors‘ workplace:
Medical Tribune, Praha
Published in:
AtheroRev 2020; 5(3): 197-199
Category:
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2020 Issue 3
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Metamizole vs. Tramadol in Postoperative Analgesia
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Memantine Eases Daily Life for Patients and Caregivers
-
All articles in this issue
- Editorial
- Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis
- Impact of SGLT2 inhibitors and real clinical practice
- Hypertriglyceridemia – today and tomorrow
- Selected biomarkers associated with atherosclerosis and bone metabolism
- Patient variability in nutritional case reports
- Mendelian randomisation studies: principle and selected examples from cardiovascular medicine
- GLP-1 receptor agonists: antidiabetic agents with antiatherogenic effect
- LIPIcontrol 2 what has changed after 3 years
- Novinky v liečbe evolokumabom: komentár k štúdiam VESALIUS-CV a FOURIER
- News in the treatment with alirocumab presented in the congress of European Society of Cardiology 2020: comment on post-hoc analysis of the ODYSSEY OUTCOMES trial
- A little change in payment means a big chance for a lot of ills
- Rešerše zajímavých článků ze zahraniční literatury
- Professor Rudolf Poledne eighty-year old
- Šobrův den 2020: XXXIV. konference o hyperlipoproteinemiích tentokrát virtuálně
- Athero Review
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Hypertriglyceridemia – today and tomorrow
- Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis
- GLP-1 receptor agonists: antidiabetic agents with antiatherogenic effect
- Mendelian randomisation studies: principle and selected examples from cardiovascular medicine